Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03136406
What this trial is testing

QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT00558207
What this trial is testing

Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 43
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Not applicableLooking for participantsNCT07007832
What this trial is testing

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Who this might be right for
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Testing effectiveness (Phase 2)Ended earlyNCT01413087
What this trial is testing

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas, Adenocarcinoma
Anchiano Therapeutics Israel Ltd. 12
Not applicableUnknownNCT04085055
What this trial is testing

Fine Needle Biopsy of Solid Pancreatic Mass Lesions

Who this might be right for
Pancreatic Neoplasms
AdventHealth 130
Early research (Phase 1)Ended earlyNCT00658801
What this trial is testing

Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 4
Testing effectiveness (Phase 2)Study completedNCT00398086
What this trial is testing

Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Celgene 67
Testing effectiveness (Phase 2)UnknownNCT06080854
What this trial is testing

AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 108
Large-scale testing (Phase 3)Not Yet RecruitingNCT06571461
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CSPC Ouyi Pharmaceutical Co., Ltd. 408
Early research (Phase 1)Study completedNCT00925769
What this trial is testing

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 32
Testing effectiveness (Phase 2)WithdrawnNCT01017822
What this trial is testing

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group
Not applicableUnknownNCT06081231
What this trial is testing

Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

Who this might be right for
Type 1 Diabetes Mellitus
Third Affiliated Hospital, Sun Yat-Sen University 500
Testing effectiveness (Phase 2)UnknownNCT06395337
What this trial is testing

Multimodal Imaging in Rectal Cancer & Pancreatic Cancer

Who this might be right for
Rectal CancerPancreatic Cancer
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT02843945
What this trial is testing

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Who this might be right for
Pancreatic Cancer
CivaTech Oncology 80
Testing effectiveness (Phase 2)Ended earlyNCT01583686
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer

Who this might be right for
Cervical CancerPancreatic CancerOvarian Cancer+2 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT04528745
What this trial is testing

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Who this might be right for
Pancreas CancerColorectal Cancer
University of Copenhagen 52
Large-scale testing (Phase 3)WithdrawnNCT02201381
What this trial is testing

Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer

Who this might be right for
CancerOverall Survival
Health Clinics Limited
Early research (Phase 1)Looking for participantsNCT07481383
What this trial is testing

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Non-resectable
Continuity Biosciences, LLC 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578337
What this trial is testing

A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.

Who this might be right for
UntreatedAdvanced Pancreatic Cancer
Nelum Corp 40
Next Page